Retatrutide 12mg is an investigational injectable peptide designed to target multiple hormone receptors involved in appetite control, blood sugar regulation, and energy balance
This is largely consistent with previous studies that have suggested that impaired renal function has minimal effect on the pharmacokinetics and pharmacodynamics of other GLP-1 receptor agonists [23,24,25,26,27]
Following CTS administration, 16S rRNA sequencing was conducted to analyze gut microbiota, and LC-MS metabolomics was employed to examine metabolic profiles
Characterized by excessive fat accumulation in the body, obesity sharply increases the risk of several diseases, such as type 2 diabetes, cardiovascular disease, and nonalcoholic fatty liver disease, and is linked to lower life expectancy
Always begin under physician supervision